Currently, mistletoe therapy is well known in some European countries but less so in others, and perhaps better known to cancer patients than those in the scientific community. Steiner predicted mistletoe could replace the surgeon's knife one day. It has not succeeded even today, it has not demonstrated a so decisive antineoplastic action. For some people this could be a source of resignation, but for others who have tried it a doubt remains about whether the potential of the medicine has yet been fully understood and exploited. These individuals believe that there is still a possibility of discovering a better application in terms of the time and manner of administration. Despite this, studies do exist that demonstrate the efficacy of the drug in anticancer therapy from a number of perspectives.
Science of the Spirit and the Mistletoe
The use of mistletoe is based on a very specific and particular understanding of the pathogenesis of tumors. It may be useful and interesting from the cultural standpoint, to readers who do not practice this type of medicine, to give a very brief description of the Steinerian intuition. [1] [2] [3] [4] [5] [6] [7] [8] For Steiner, the occurrence of a tumor is primarily the outcome, or at least the decisive factor, of an imbalance in the connections between the constituent parts of the human being, which are the etheric body (vitalizing, generative, vital life forces) and the physical body (mineral, biochemical man), and in relation to the superior man, which is soul and ego. [9] [10] [11] [12] [13] [14] Soul, or the astral body, is an inner life of feelings and sentience that is present throughout the physical and etheric body, giving them impulses. The ego, self-aware and spirit, endows the human being as a whole with special abilities, raising them above the animal kingdom. It is precisely in the T he introduction of mistletoe as an antineoplastic therapy goes back to 1920 through 1924 on the basis of the indication proposed by Rudolf Steiner, who was the first to recommend the use of this plant although it had been known from ancient times for quite different properties and other therapeutic applications. Steiner (1861 Steiner ( -1925 was an Austrian philosopher, literary scholar, educator, artist, playwright, and social thinker. He was the founder of anthroposophy, Waldorf education, biodynamic agriculture, and the new artistic form of eurythmy. At the beginning of the last century, with the physician Ita Wegman, at he established anthroposophical medicine essentially based on the spiritual scientific view of a healthy human being in close harmony and interaction with the different levels of creation and how this may be lost in a state of illness. Mistletoe is one of the oldest antiblastic medicines and is still in fact one of the most used, at least in Europe. Only white-berried mistletoe (Viscum album L.
[Viscaceae]) is used to treat cancer. It has different subspecies respectively growing on deciduous hardwood trees like the apple, oak, ash, and elm (var album), or growing coniferous tress like pine and fir (Pinus and Abies varieties).
Laboratory research has identified the components of this drug through hundreds of analyses. It is obtained via a complex process from both the winter and summer varieties of the plant which are then appropriately mixed. Scientific spiritual researchers have also uncovered the deeper aspects and meanings of this therapeutic action, since their image of man includes not only his physical and functional traits, but also his psychological and spiritual traits. imbalance between the physical body and etheric body that we identify the activation of the pathological process, which we know as a tumor. A rebellion of the physical body occurs in a specific organ because of the forces of this organ prevailing over those of the etheric body. Steiner pointed out:
To observe cancer correctly, it should definitely be seendespite its variety of forms-as a revolution of certain physical forces against the forces of the etheric body. The fact that in certain internal carcinomatous formations areas of hard substance are found (which are also present as a tendency, even though less evidently, in cancers at more superficial sites), shows how the physical formation gains the upper hand over its corresponding etheric formation at that site. If we closely study these two groups of phenomena, we are able to see with our own eyes, so to speak, that the inflammatory and ulcerative processes precisely represent the polar opposite of the tumor formations. 2 Anthroposophic physicians would state that in a specific organ matter prevails over life, the forces of indurations and death prevail over those of fluidity and differentiated growth, and the tendency toward belowtoward the earth-prevails over the ascent toward the sky. This happens when what is mineral, which falls in response to gravity, is compared to what is vegetal, which rises vertically in response to forces, which call from the heights of the terrestrial atmosphere.
Must one therefore conclude that a defective etheric body is at the origin of all this? It is difficult to believe that the problem is solely here. We believe that we are speaking of a cellular process characterized by rapid, uncontrolled, aggressive growth. In reality, the final outcome of rebellion by the physical body simply occurs because the etheric body is what we might call exhausted through an excess of activity not guided or formed by the astral body and the organization of the ego. A waste of vital energy, not directed, with no purpose, so that an excess etheric body comes to lack direction and therefore individuality.
According to Steiner, the superior man should therefore define the instigating factor as a lack of control over the forces of growth. We could say that the sphere of the soul, of feelings and thoughts and of the awareness of the ego and of one's destiny, are no longer capable of being decisive for the movement and the action initiated at a certain moment. Outside of this direction growth and vitality end up in materiality and are finally dominated by matter. Steiner stated, Cancer cannot be understood until it is realized that it involves the domination of the etheric body, which is not held in check, not destroyed, by a suitable action of the astral body and the organization of the ego. The problem is this: what is required to strengthen partially the astral organization and the organization of the ego to the advantage of the affected organ, so that the exuberant etheric organization is appropriately destroyed? This is the problem, set out first in abstract terms that leads us to engage in cancer therapy. 1(p.219) At the same time that he proposed these aetiopathogenetic interpretations, Steiner provided a precise specific indication, which indeed has no precursor in the history of natural medicine or even in homeopathy. We can therefore call it an original indication and it has instigated a process of applied research which is probably still in its infancy. We are witnesses of tangible results, but with our expectations still wide open, as we shall see.
Here is what is said about mistletoe in Anthroposophic Knowledge of Man and Medicine. 1 In the case of cancer, we try especially to recognize it at the proper time, something that is usually made difficult by the patients, but a cancer recognized at the proper time can be combated medicinally with mistletoe preparations. I do not wish to speak at this juncture of the value or not of surgical treatment nor of the fact that this is often necessary; I wish only to indicate how even the most serious cases of disease can be studied on the basis of a real knowledge of the human being, in such a way that it can be used to arrive at healing processes which arise from within. (p.125) … the mistletoe is therefore certainly the medicine which, when activated in the proper manner, should one day become the replacement for the surgeon's knife in the case of neoplastic diseases. We need only to find the mode of appropriate use of the fruits of the mistletoe to obtain a true medicine, and without passing over the other forces of the mistletoe. 1(p.196) In Anthroposophic Knowledge of Man and Medicine Steiner returns to the concept of an activity of the etheric body, which escapes from the formative forces of the astral body and of the ego and indicates the mistletoe as the exact remedy for this imbalance.
… the mistletoe carries from the tree what this supplies when it has too little physical material, when the etheric in it is exuberant. An exuberant etheric is delivered to the mistletoe by the tree. When examined in depth, this phenomenon tells us that if the mistletoe is prepared in a suitable manner, it can really transfer to humans the etheric derived from the tree, something that happens in certain circumstances when injections are administered. This phenomenon tells us that the exterior substance of mistletoe takes on the exuberant etheric substance of the cancer; by resisting the physical substance it reinforces the action of the astral body and thereby leads the tumor to fragment, to dissolve. By introducing the substance of the mistletoe into the human body we are in fact introducing the etheric substance of the tree. The etheric substance of the tree transported into the human subject attracts the mistletoe, and acts therefore by strengthening the astral body of the subject. 1(p.229) Steiner has arrived at the point of believing that action on the astral body, and therefore action on the soul, is the core of cancer therapy. Hedwig Erasmy sets out the Steiner concepts as follows 14 : This then is how the origin of the neoplastic disease is presented: it is a formative process in human beings, derived from the twelve directions of the universe, uncontrolled, a deviational formation in the human being. This process of formation of the human being, which is active lifelong in bone formation, falls more and more under the control of the human being, ie, under the control of the ego as the coworker. Embryonic formative forces are active in producing deviations, thereby giving rise to the tumor. The ego is the moving force in the vehement process of pulverization and is always present in the human circulation as the centre of the vortex. The pulverization process that constitutes the origin of the neoplastic disease is the setting for the ego, retained in the sensory balance of the etheric human being.
Along with the base mistletoe preparation the cancer patient receives the health-giving vortex, which through its presence in the blood circulation is exposed to the danger of a deviated process of pulverization. This provides the ego with a healthy model in place of the diseased one that is present.
Through the base of mistletoe medicine we try to restore a state of equilibrium to the sensory chaos. In fact, all the forces of the universe brought to the body situation without the control of the ego make up the neoplastic disease. In this way the mistletoe presents itself on behalf of the cosmic order, becoming a weapon in the hands of the ego. By virtue of the mistletoe as medicine, an equilibrium of the forces of health is created in the etheric body and it becomes possible therefore to fight the neoplastic disease.
Mainstream Medicine and Mistletoe
When we wish to explain the action of mistletoe in the terms of modern science, we cite not only its action on the immune system, but also its direct antiproliferative action on the cancer cells. Since the 1980s the properties of the active substances of mistletoe have been studied in detail, especially viscotoxins, lectins, and polysaccharides, as well as its other components.
However, the viscotoxins and lectins, both of which are protein molecules, have very different characteristics, in some ways directly opposite. The lectins are in the dark behind the mistletoe body, particularly in the haustorium (attachment to the host plant), which is where ordinary plants develop their roots. The viscotoxins are on the periphery, especially in the leaves; there are small quantities in the haustorium. They are in contact with light. The lectins are more labile molecules, whereas the viscotoxins are more resistant to heat and proteolysis. The former express a slow reaction, block protein synthesis, and should be classified as cytostatic; the latter express a more rapid reaction, acts on the cell membrane, and are cytolytic.
The polysaccharides, extracted from all plant components, produce an immunostimulant action, potentiate the action of natural killer lymphocytes, and activate the complement system. Laboratory research has permitted characterization of the combined action of these components of mistletoe, which is explained in the following effects 15-26 :
• cytotoxicity in tumor cell cultures, • stimulus for lymphocytic proliferation, • numerical increase and phagocytic activation of the neutrophils, and • increased number of CD4+ cells in the circulation of HIV-positive patients.
How can we convert these laboratory effects to in vivo therapeutic use? The following findings from clinical studies summarize the therapeutic effects that have been observed with mistletoe 27-39 :
• improvement in general clinical condition;
• slowing of tumor growth;
• improvement in cancer pain;
• improved quality of life (improved appetite, sleep, general wellbeing); • improvement in mood, antidepressive action;
• stimulation of the immune defenses and thereby a reduction in infections; and • improved tolerability of chemotherapy and radiotherapy when included as a therapeutic resource.
Because of the intrinsic qualities of mistletoe and its manner of growth it is thought that all of these concrete actions occur through the medium of two features as reported by cured patients-experience of heat and of light. The former feature, mostly perceived in its physical aspect, was projected by Steiner as an indispensable condition. Without an increase in the body temperature there can be no real efficacy, since heat is the instrument used in the organization of the ego. In practice we can easily point out a patients temperature increase, not a real fever but approximately a tenth of degree more, closer to 38°C, between, before, and during mistletoe therapy. Light on the other hand represents a predominantly psychologicalspiritual aspect and therefore is captured through an approach with the patient, which gives attention to these key aspects; something not always present in the traditional medical sciences.
In addition to mistletoe preparations, anthroposophic treatment generally includes psycho spiritual exploration as well as other therapies such as writing or journaling.
The key importance of the biographical history in this dynamic view of the disease is part of the person-patient totality. It is this, which enables the rediscovery of the ego as a forming and differentiating spirit, that acts as a new vital connection between history and the reformulation of an image projected into the future. [40] [41] [42] [43] This biographical history may be a potentiating element in therapeutic synchrony with mistletoe, just like other specialized therapies well known to anthroposophic clinics and care centers (ie, eurhythmy, oil dispersion baths, rhythmic massage, art therapies). These therapies in some way complete the work of mistletoe and biographical narration, acting on the other constituent parts of the patient. In eurythmy, patients practice specific movements of the limbs, which have a direct stimulating effect on their own vital energies. What is special is that with every gesture the whole human being is addressed in his will, feeling, and thinking. Apart from the physical effect, this is experienced as a general harmonization of real benefit.
Art therapies are based on the elementary media used in the respective arts. The media include form in sculpture and modeling, color in painting, intervals in music, and consonants in speech. They act on the emotional sphere and excite the forces of the soul. Rhythmic massage is a variant of classic massage. When applied rhythmically the aim is to stimulate powers of healing, balance out one-sided developments in the organism, and restore harmony. Depending on the desired effect, methods are chosen to stimulate or soothe, give form, decongest, and above all provide real warmth. If the clinical effects described above can be documented in a scientific study supported by statistical significance (and examples are available), then the totality of these physical-functional and psychological-spiritual components can become important evidence of efficacy, if documented with representative and not isolated case reports. The importance lies precisely in the confirmation of other similar cases, even though they are insufficient in numbers to represent a statistically homogeneous group.
Some representative cases will be described below that support the possibility of efficacy in the different aspects listed above. One case addresses a patient who refuses all conventional treatment, which is a situation frequently observed by oncologists and integrative practitioners. Even though an individual case is far from being a statistical demonstration of efficacy, its representative quality may be a small contribution to the formulation of prospective clinical protocols and may suggest indications for objectives. This is the understanding of the clinical case reports presented below. According to Italian law on privacy personal data was not related. In every case informed consent from the patients to use their histories was obtained.
A brief note on the mistletoe preparations used: the patients described here were treated in Italy, where preparations are available of Viscum album fermentatum Mali, Pini and Quercus (with possible additions of metals) in series O, I, II, at fixed doses increasing by package and among series. Typically Viscum album fermentatum Mali is prescribed in women with breast cancer (premenopausal), genitourinary cancer, and osteo-muscolar sarcomas. Viscum album fermentatum Pini is used in postmenopausal breast cancer and skin and rhino pharynx tumors in both sexes. Viscum album fermentatum Quercus is generally used in the other tumors in men. This is only a common guideline and not an absolute rule. All mistletoe preparations have a ponderal dosage and are not considered homeopathic. They are generally administered subcutaneously at regular intervals two to three times a week, occasionally by intravenous injection.
Clinical Case Reports Patient 1
Patient 1 is a 68-year-old woman with the principal diagnosis of pelvic lymph node recurrence of tubal malignancy. The family medical history of the patient includes a sister who had surgery for breast cancer, while her mother died of cancer of the large intestine. Her previous medical history includes an appendectomy and an episode of pleurisy in her youth. She has been HCVpositive for 7 years, with viral RNA detected. Five years ago she had a surgical intervention for a lesion of the right rotator cuff. For several years she has had bouts of depression, resulting in the almost continuous use of tricyclic antidepressant drugs and periodically of lithium. She has been followed at her local psychiatric clinic. The patient is married, has no children, has not had any abortions or miscarriages, does not engage in the prolonged use of oestroprogestins, and has not had previous gynaecological problems.
In June 2004, following an episode of metrorrhagia, a pelvic mass was found which measured 15 x 10 x 7 cm in diameter. She underwent a laparohysterectomy on July 5, 2004; a lymphadenectomy was not performed. An adenocarcinoma of tubal origin was diagnosed, pT2 Nx M0-G2-FIGO stage II. The ovaries and endometrium were not involved. The patient received adjuvant chemotherapy with carboplatin (AUC 5) plus paclitaxel (175 mg/m 2 ) for 6 cycles, from August 5, 2004 to December 30, 2004 . Side effects are complete alopecia, marked asthenia, grade 2 anaemia, grade 3 nausea, and vomiting (grade 2 in the first 2 cycles). She had regular follow-up visits, and by the end of chemotherapy the neoplastic markers had normalized. In April 2006 an elevation of Ca 15.3 antigen was detected (from 29.0 to 59.9). A chest and abdominal CT scan was performed. This indicated the presence of lymph nodes at the lumbo-aortic level in the anterocaval area, with compression of the inferior vena cava. A PET scan was performed which confirmed the lumbo-aortic lesion and at the same time excluded other localizations. On June 26, 2006, the patient underwent a pelvic and lumbo-aortic lymphadenectomy, omentectomy, and peritoneal lavage. Histological examination confirmed the presence of massive metastases with extended areas of necrosis secondary to grade 2 adenocarcinoma of the interaortocaval lymph nodes, compatible with a primary tubal neoplasm. The pelvic lymph nodes proved negative. A further adjuvant chemotherapy plan was proposed to the patient in which the carboplatin-paclitaxel regimen would be used again in view of the severity of the recurrence and the duration of the disease-free interval (18 months). The patient was very concerned about accepting the therapy in view of her previous experience of toxicity and poor quality of life during the treatment cycles. The decision was complicated by the presence of depression, which was very much accentuated in the immediate post-intervention period. During our consultation the patient asked if no natural medicine existed that would help her better tolerate the side effects, or something that would strengthen the immune system (she had heard general allusions to preparations of this type). I proposed therapy with Viscum Mali at this point. It would be initiated 20 days prior to the scheduled start of chemotherapy. The patient began treatment with Viscum album fermentatum Mali, starting with series O. Once the first pack had been taken without side effects and without fever she transferred to series I. A reaction occurred-limited local flushing. Once 2 packs were taken, she transferred to series II, still with a local reaction, which resolved on the day of administration. She has also been prescribed Aurum metallicum praeparatum trit. D30 in the morning, and Argentum metallicum praeparatum dil. D20 in the evening. The metallic preparations are homeopathic dilutions of metals used in anthroposophic medicine. 44 The purpose was to address depression and weakness with Aurum and improve relaxation at night with argentum. She continues on Hypericum Auro cultum associated with Viscum Mali series II. The therapy induced moderate anaemia and fatigue. Levico mineral water (a reequilibrating remedy with iron and arsenic very appreciated by Steiner) has been added morning and evening.
Apart from alopecia, the only manifestations of toxicity in the patient during the 6 cycles of chemotherapy were grade 1 nausea and grade 1 anaemia. The fact that her quality of life exceeded her expectations had a positive effect on her psychological state. The patient reported the sensation of being on top of the situation and of possessing an interior force, which she had not anticipated. When the therapy was finished, she was scheduled to continue on the preparation in cycles.
Comment. In my oncological experience, both in hospitals and other situations, I have found cases of people who, while believing and accepting the offer of treatment with anthroposophic medicines, at the same time do not wish to even discuss conventional treatments with chemotherapy or radiotherapy suggested by the cancer clinics to which they are assigned. This situation of compromise, in which the anthroposophic therapy assumes an apparently adjunctive role, may also reveal an evident capacity of the mistletoe to make the patient more resistant to the toxicity of the chemotherapy agents and improve quality of life during the period of therapy. I have seen patients helped to a surprising extent who were impaired by their toxicity in different degrees and who were treated with regimens of carboplatin-paclitaxel for ovarian cancer; epirubicin, cyclophosphamide, 5 fluorouracil (ECF) chemotherapy for gastric tumors; and anthracycline-taxane for breast cancer. In a limited study population there always remains a doubt about the lack of a control. This is also the limitation of so many of our experiences in this field. The case we described is exemplary since, in the context of reporting an individual case, it suggests the possibility of comparing the quality of life during the same chemotherapy at different times in the same patient, both with and without use of the mistletoe preparation. The finding of a significant reduction in toxicity with the use of this medicine obviously does not permit considerations of statistical significance, but it invites us to design case-control studies in which the toxicity and the level of quality of life can be determined, just as when defining the type of chemotherapy to select. A study, which targets the disease-free interval and survival, would be of great interest, but also demanding. It would require homogeneity of both the treatment schedule and also the disease stage.
Patient 2
This patient is a 65-year-old woman with the principal diagnosis of metastatic breast cancer (skin, lung). The patient has a long history of more than 20 years of breast cancer, with numerous courses of treatment. There is nothing of significance in the family medical history. Hypertension is the sole significant pathological condition. The history of the patient's cancer began in 1985, with the finding of a breast nodule in the right upper outer quadrant. Patey mastectomy with lymphadenectomy was performed. Fourteen lymph nodes were removed, all negative. The definitive diagnosis was infiltrating ductal carcinoma pT2 N0 M0, with hormonal receptors unknown. No precautionary therapy of any type was suggested to the patient.
In 2001 metastases were detected. These included a cutaneous metastasis on the right chest wall and one in the left lung. The patient underwent 3 cycles of 5 fluorouracil, epirubicin, cyclophosphamide (FEC) chemotherapy, radiotherapy of the right chest, then another 3 cycles, which were completed on August 7, 2001. Beginning on August 28, 2001 the patient underwent maintenance therapy with anastrozole. A follow-up CT scan showed a visible right thoracic opacity, but the remainder was clear; the skin lesions were no longer visible. On October 8, 2003, a recurrence of the disease was detected on the skin. Because of the asymptomatic presentation a second hormonal regimen with exemestane was proposed to the patient. She remained stable until April 2004, when the presence of diverse cutaneous nodules was observed, indicating progression of the disease, which was confirmed by an increase in the carcinoembryonic antigen (CEA) level. The nodules were removed surgically and on April 27, 2004 , and weekly paclitaxel administration was started, with a complete response. The therapy was extended to November 2004, without any specific toxicity. On December 2004 (when she came into observation) hormonal therapy was restarted to maintain the response. Letrozole was selected and disease remission was obtained until December 6, 2005, when recurrence of the disease was detected. A further course of chemotherapy with vinorelbine monotherapy was administered on this day and then on day 8. This course is repeated after 21 days. Again there was rapid disappearance of the lesion and a reduction of the pulmonary radiographic lesion. There was no significant toxicity initially. In April, after the onset of fever and cough, a diagnosis was made of bronchopneumonia on the right side. During her stay in the medical ward the mycotic nature of her illness was diagnosed (candidiasis, grade 3 infection). The status of the immune system of the patient therefore appeared to be strongly challenged by the therapies she received, but without any evidence of significant leukopenia. The chemotherapy was discontinued and hormonal therapy with exemestane restarted to help maintain the remission. This, however, was of brief duration and in June 2006 the further appearance of diffuse cutaneous lesions on the right chest were observed. The choice of therapy was difficult. The patient insisted on continuing with conventional chemotherapy if possible, and furthermore the hormonal therapy was unable to offer any further hope of response.
While taking account of the risk of immunosuppression, we agreed with the patient to resume treatment with vinorelbine under the previous regimen, and to add Viscum album fermentatum Pini as an immunostimulant. The patient started therapy with Viscum album fermentatum Pini, beginning with series O and moving up to series 1, with rather marked skin flushing and warmth. It was necessary to discontinue series 2 at the higher dose. It was decided instead to maintain series 1 of the Viscum Pini with Hg, at 3 administrations per week. Because of the predominantly cutaneous involvement most recently, we added Quarz trit. D6 and Argentum metallicum D10 in a triturated compound. We consider them active toward skin lesions.
The result has been that the patient continued on chemotherapy up to January 31, 2007, with partial remission of the skin lesions and with the pulmonary condition unchanged. In February 2007 chemotherapy was discontinued and it was decided to continue with mistletoe and the other anthroposophic preparations alone. The clinical picture has remained stable up to August 2007. Given the absence of symptoms in the patient this result should be considered satisfactory.
Comment. The infections that appear as complications during chemotherapy are evidence of immunosuppression of the patient, which was only partly take account of and monitored in the clinical practice, usually by checking the leukocyte count and differential composition and modulating cycle times and doses according to neutrophil levels, while ignoring, for all practical purposes, the lymphocyte populations. In this case report mistletoe enabled chemotherapy to be continued in a manner identical to that of the preceding course (vinorelbine), which had produced a response to the skin disease, but also evidently caused immunosuppression, as shown by the occurrence of fungal pneumonia. On the basis of this event, continuation of the chemotherapy was potentially very risky and the function of mistletoe in the nonoccurrence of infection appears to be unequivocal.
The other major question on the efficacy of mistletoe is its potential to inhibit tumor growth directly, a capability which, as we have seen, some components of the medicine seem to possess in laboratory tests. In this case I believe it may be useful to indicate the role played in the stabilization of the skin disease by mistletoe therapy alone, which was revealed 6 months after the discontinuation of the chemotherapy agents. This patient therefore seems to us to illustrate the immunoprotective role of the preparation, and to some extent, also its direct anticancer effect.
Oncology comes across cases of discontinuation of chemotherapy after a certain number of cycles for a variety of reasons including the following: further efficacy through continuation of further cycles has not been demonstrated, the patient is elderly and prefers a waiting approach, he/she has reached a response plateau, is asymptomatic and has a good quality of life in which a watchful waiting approach is preferred, or simply because no further effective chemotherapeutic medicine exists. These are situations in which the benefit of mistletoe as maintenance therapy in the nonchemotherapeutic phase may be suggested even in the area of conventional oncology.
Patient 3
This patient is a 66-year-old woman with the principal diagnosis of surgically treated gastric cancer. The patient has no significant family medical history. She underwent tonsillectomy and appendectomy in her youth. At age 30 she had a cholecystectomy. She has 2 children, a boy and a girl, and is a housewife. There were no significant events until January 2005, the year in which her husband died of pancreatic cancer.
In April 2006 a gastroscopy was performed following weight loss and epigastric pain. This revealed antral carcinoma. The patient underwent a total gastrectomy on April 14, 2006 . The cancer consisted of disseminated undifferentiated carcinoma, with extensive involvement of the lymph nodes (pT3 N2 M0 with 7 lymph nodes positive from the lesser curve and 5 from the greater curve). The distal resection margin was infiltrated. The patient, who had been followed elsewhere, was advised to have adjuvant chemotherapy in view of the almost certain probability of the presence of residual microscopic disease. On May 24, 2005 she began treatment with anthracycline, platinum, and 5-fluorouracil (ECF), following placement of a central catheter.
It should be emphasized that the start of the treatment occurred at a time in which the patient was not ingesting sufficient food and her nutritional status was not yet adequate. She had not regained weight. She also continued to suffer from depression, with a strong sense of darkness and prostration. The outcome was catastrophic. After the first cycle, uncontrollable emesis set in, as well as an absolute incapacity to take in food or liquids. Next, she was admitted to a hospital because of severe physical deterioration (grade 4 gastrointestinal toxicity). During her stay she received therapy by infusion and parenteral nutrition for some time. After discharge, her condition was extremely poor. The patient came to my observation on July 7, 2006, with increased weight loss relative to the preintervention period, absolute refusal of food and incapacity to undertake any nutritional program.
The situation was worsened by a marked sense of loneliness and absence of motivation to continue to live. Viscum album fermentatum Mali was prescribed for the patient, rising from series 0 to series 2 each time, up until January 2007. A vial of Aurum naturale D10/Prunus spinosa D5 was added for 2 weeks, and then drops and triturated Ferrum sidereum D6. We consider these metals, and Prunus in particular, a very good remedy for fatigue.
After 2 months the subjective result was already evident. At the follow-up visit the patient appeared brighter and more motivated to select some of her favorite foods, choosing predominantly vegetarian foods despite pressure from her relatives. Her weight increased by 2 kg, and this was clinically evident. We continued the therapy for 6 months. In December through January the patient underwent a follow-up CT and then a PET scan, both of which were negative. Her blood profile returned to normal (Hb 13.8 compared with a baseline 10.6). Her weight did not increase further but asthenia was no longer present and she succeeded in performing her normal domestic activities and pursuing her usual relationships.
Comment. The state of stagnating malaise and debilitation after surgical intervention and especially following the inappropriate and untimely cycle of chemotherapy were overcome in a rather short period, so much so that one is led to deduce from the situation that the anthroposophic therapy somehow accelerated the recovery, or better it was a decisive factor. It appeared evident 3 months later that a change in her psychological status had occurred, with greater reactivity to her situation and motivation to start over. The refusal of food, which was a refusal to go on living, risked upsetting her relationship with her children by generating frustration and hardening of family relationships, similar to what occurs in anorexia. Add to that the insecurity of not being able to continue with the chemotherapy, which had been presented as essential for halting the disease.
This case, in which the function of mistletoe in the recovery of coenesthesia is evident, should indicate the necessity of studies on quality of life as the principal endpoint, but above all to define an investigation method for adequately documenting its efficacy on the extent and time of recovery.
Patient 4
Patient 4 is a 46-year-old man with the principal diagnosis of surgically treated gastric carcinoma. The patient was 46 years old at the time of onset of the disease in 1999. He was reared in a working class family and attended university only with substantial sacrifice on the part of his parents. He therefore retained the feeling of not having convincingly repaid the efforts of his parents. As a liberal arts teacher he thoroughly enjoys his teaching work but is poorly paid. He married a colleague at the age of 34, did not have children, and did not search for reasons why. His lifestyle revolved around numerous trips, restaurants, shows, and cultural events. At a certain point, which we will learn more about below, he began to get the feeling of not having a future and therefore also not having a sense of the present. He did not, however, discuss this with his wife, with whom he could not communicate his existential problems. The patient says that for some time he had been keeping everything inside, in particular his feelings of sadness and rage, which were increasing.
For some time he had been noticing epigastric pain, loss of appetite, and weight loss. A gastroscopy prescribed by his family doctor revealed, in addition to signs of gastritis, the presence of early gastric cancer. The patient underwent a total gastrectomy in June 2001 (T1 N0 M0, adenocarcinoma with signet ring cells). He found it very tiring to recover his normal pace and pleasure in food. After 3 months he still had not succeeded in eating a full meal; food looked unappetizing and provoked rather sudden nausea. He did not succeed in regaining his preoperative weight. In recent months he had lost about 8 kg.
There was no indication for chemotherapy, but he felt insecure and helpless in face of a possible recurrence, which in his view was a matter of fate. He said he felt he was getting old and that his posture had changed. He leaned forward more to hide the long purple longitudinal scar. He felt old and without energy.
I suggested Viscum album Quercus therapy to him, which we would continue for a year as series 1, then for 6 months more at three times per week, and then twice a week. In subsequent years he would undergo cycles of three months of therapy alternating with three of suspension. For the difficult convalescence I prescribed Aurum Prunus drops and sloe syrup. I saw that he badly needed sunshine, which returned with the spring. In the space of three months his appetite returned, but with little liking for meat dishes. Despite his vegetarian regimen, which in fact I encouraged, his hemoglobin level rose from 10.0 after the operation to 12.4 at 3 months, with normalization of the sideraemia. In the same space of time he experienced a weight gain of 3 kg, and a further gradual gain of 5 kg in the subsequent 6 months.
The patient returned to work with sufficient energy, and he began to write again. During the therapy I felt it warranted to work on his many personal questions, on his feeling of not having responded correctly, and on his search for meaning. We thus worked on the discovery of meaning through the patient's writing, which was eventually recognized as a gift.
Comment. The use of mistletoe in this case is closely linked to the detailed biographical investigation, obtained concomitantly with the clinical examinations. At the start, the patient displayed substantial needs and a liking for this type of investigation, which was partly done also in writing, something that he found appealing. The function of mistletoe for this patient is typically physical, psychological, and existential. This quasi-global action of the medicine is difficult to demonstrate in clinical studies. It is typically detected through attention and a vision of the individual's biographical development, which can be considered interesting and scientific only from a certain perspective-the perspective of the science of the spirit.
Patient 5
This patient is a 58 year-old woman with the principal diagnosis of lumbo-aortic lymph node recurrence of ovarian cancer. The patient did not have any serious diseases until the year 2000, but her life was not easy for other reasons. She spent her infancy and youth with a mother who was a nurse and an older brother, but never knew her father. She had a very unhappy adolescence, with affective disappointments and conflicts with the rest of the family. After 20 years she met the man whom she would marry and with whom she would have a tranquil and stabile relationship. Regarding her husband, the only complaint she had was of feeling lonely and ignored now and then, but so were other women, she said. She chose the profession of a physical therapist, and was very happy with it.
In 2000 she was diagnosed with ovarian cancer, after a period of months in which she reported respiratory disorders without cause-she attributed them to anxietycharacterized by continual deep inspirations with difficulty in releasing her breath, an incapacity to exhale completely, of emptying herself. She underwent a laparohysterectomy and the final investigation diagnosed a bilateral serous cystoadenocarcinoma, pT3 N1 M0-G3-FIGO stage III C. After 3 cycles of therapy with epirubicin plus paclitaxel, she was enrolled in an experimental high-dose chemotherapy protocol at a centre in Milan. The experience was shocking. She emerged physically and emotionally drained, incapable of feeling and thinking. Then everything seemed to turn for the better for some years. The patient spontaneously associated the onset of the tumor with a period of breakdown in her 20-year-old son's life. The son had been beset for years with problems of drug dependence. The disease, the drama, and the concrete possibility of dying brought him back in his tracks. He became close to his mother and accepted the idea of treatment. Everything went well for some years.
In March 2007, when she first came to my observation, she underwent investigations because of an increase in tumor markers. The CT and PET scans detected a recurrence of a 2 cm diameter tumor in the left paraaortic area. She was evaluated at a leading Milan centre for a minimally invasive surgical technique, but was excluded. The affair precipitated a very strong emotional setback. Inevitably, in view of the connection she made spontaneously with the first onset of the disease, I asked her if there were any significant facts in the preceding period. In response to the question the patient burst out in tears and reported that her son, now cured and independent, was about to leave to live by himself. This was an otherwise normal occurrence that she had helped him organize, but at the moment of separation he snatched the keys from her hand and told her that her job was done and that he would not tolerate any further meddling. Several months of sadness followed, which the patient summarized in the question, "Now I'm cured, but what do I do with my life?" The patient wished to face her recurrence with awareness and with participation in the choice of the type of therapy, unlike the first time in which she was subjected to imposed aggressive therapy because of her inferior status in relation to the medical profession. In fact, she refused the surgical intervention a priori and did not wish to hear any more talk of chemotherapy. In this situation she contacted me in response to the advice of a friend who is undergoing treatment with anthroposophic medicines following breast surgery.
We decided to start with Viscum Mali series O, and transfer immediately to series I. At the start I did not combine the therapy with other medicines since the patient already was receiving therapy with ayurvedic medicines which she believed in. Only several months later did I add Argentum met. praeparatum D3 in dilution and Cuprum met. praeparatum D20 (night-relaxing power and affinity of Argentum for genital apparatus, general relaxing and warmth inducing action of Cuprum) initially in the evening, and then Hypericum Auro cultum Rh D3 in the morning. In June 2007 she transferred to Viscum series I with Ag and after one pack we decided to proceed with series II of the same type. The patient reported a not unpleasant feeling of warmth and limited local flushing that does not last longer than one day after the injection. I reminded the patient that the task of curing oneself on mistletoe therapy still requires a personal biographical investigation, which would take about 10 sessions. Her life indeed is particularly rich in drama and emotions where painful memories and emotions would emerge on which we must share our views. Concurrently she would undergo a rhythmic massage program, performed by a specially trained massage therapist. We arranged with the patient to check her Ca 125 antigen level and to track the disease for occurrences on CT or PET. Since the former remains substantially unchanged (between 40 and 50), we decided to obtain the CT scan at the end of August, 6 months after the treatment. It should be noted that the patient firmly requested that diagnostic follow-up visits not be scheduled close together, since they induce a state of anxiety for her.
During the months of the biographical investigation, the patient's eyes became brighter, her forehead less lined, and her face less hard. Her breathing, she reports, was more rhythmic and regular, her posture was straighter and more confident, her gaze was directly forward rather than downwards, and her shoulders less bent. On the CT in August, the neoplasm still appeared isolated and the diameter was 17 mm. This result, which is apparently weak in terms of a response, should be evaluated in volumetric terms. If we assume a spherical shape for the neoplasms, the volume is reduced in a more marked manner than might seem. With a diameter of 20 mm and a diameter of 17 mm the ratio between the two volumes is 1.63 and the reduction in volume is in fact 38.59%. In the light of this geometric concept, the patient took heart and we decided to continue the investigation and with the same nonharassing form of monitoring. The patient says that whoever chooses this path must give it time to work and must find resources within oneself.
Comment. That an individual case does not make a statistic is obvious, not only in mainstream oncology but in science in general. Improvements, even spontaneous improvements, are often reported. The statement is made but no details are ever given that suggest a solution. This case seems to us to indicate at least that everything that happened may have modified the history of the disease, even if slowly. In the natural order of things, the neoplasm would have progressed and not regressed. It might be objected that we do not have a biopsy demonstration of the neoplasm. This is true, we are relying on the CT, on the PET, and on the Ca 125 which indeed did change. The patient, in any case, did not accept any other procedures. With all these limitations, we still maintain that the case suggests how a recurrence of disease may instigate a process of work on the Ego, with the result that one repossesses one's motives and meanings, basically repossesses oneself. Finally, the development of further studies is merited, that could explore the possibility of direct cytostatic effects of mistletoe, or of mistletoe in a more complex therapeutic setting.
Conclusions
For more than 80 years mistletoe has been used in antitumor therapy by many European physicians and others. The observations of positive effects from the clinical standpoint, in agreement with what has been detected by laboratory research, are part and parcel of the experiential tradition of anthroposophic doctors. A brief description of representative clinical cases is not intended to be a final demonstration, but merely constitutes a starting point, on the basis of which we can set the direction for initiating prospective clinical studies. From these there may emerge supportive data not only on the efficacy of mistletoe in improving the quality of life of cancer patients, but also on its direct action in inhibiting neoplastic growth within the special context of care of the whole person, which is characteristic of anthroposophic medicine.
